Regeneron's weight-loss drug helps preserve muscle mass in study-February 2024-www.financetom.com

Regeneron's weight-loss drug helps preserve muscle mass in study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Regeneron's weight-loss drug helps preserve muscle mass in study

Jun 2, 2025 4:36 AM

June 2 (Reuters) - Regeneron Pharmaceuticals ( REGN )

said on Monday its experimental weight-loss drug combination

helped preserve muscle mass in a mid-stage study.

Previous page： --UnitedHealth Maintains Quarterly Dividend at $2.10 Per Share; Payable Sept. 24 to Shareholders on Sept. 16 Next page： V2X Set Up Heading into H2 'Encouraging,' RBC Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--UnitedHealth Maintains Quarterly Dividend at $2.10 Per Share; Payable Sept. 24 to Shareholders on Sept. 16

Aug 7, 2024

12:05 PM EDT, 08/07/2024 (MT Newswires) -- Price: 569.74, Change: +1.39, Percent Change: +0.24 ...

V2X Set Up Heading into H2 'Encouraging,' RBC Says

Aug 7, 2024

12:08 PM EDT, 08/07/2024 (MT Newswires) -- V2X's (VVX) Q2 results were driven by strong international sales and the company's H2 set up for revenue, bookings, free cash flow and margin is encouraging, RBC Capital Markets said in a note emailed Wednesday. The firm said V2X's Q2 free cash flow was $25 million, half of the $50 million consensus, and...

Lyft's Q3 Gross Bookings, Adjusted EBITDA Guidance 'Disappointing,' Wedbush Says

Aug 7, 2024

11:59 AM EDT, 08/07/2024 (MT Newswires) -- Lyft ( LYFT ) shares were down nearly 12% in recent trading, reflecting the company's disappointing Q3 guidance for gross bookings and adjusted earnings before interest, taxes, depreciation and amortization, Wedbush Securities said in a note Wednesday. The company expects Q3 gross bookings of $4 billion to $4.1 billion, implying year over year...

Northern Oil & Gas, SM Energy Exercise Option to Buy More Uinta Basin Assets

Aug 7, 2024

12:06 PM EDT, 08/07/2024 (MT Newswires) -- Northern Oil & Gas (NOG) said Wednesday that the company and SM Energy ( SM ) have exercised an option to jointly buy more Uinta Basin assets next to their XCL Resources asset acquisition. Northern Oil said it exercised an option to buy a 20% stake in the assets, which were owned before...